Exchange traded funds (ETFs) certainly are becoming increasingly popular with Australian investors.
Last year the total funds invested into ETFs in Australia reached $50 billion. Incredibly, this number is expected to double to $100 billion by 2022.
I don’t find this overly surprising considering the advantages that they offer investors.
Investing globally or into certain themes has been a very challenging endeavour for investors in the past. But now, thanks to ETFs, it is as simple as opening up a brokerage account.
Given the growing popularity of ETFs, you won’t be surprised to learn that there is an increasing collection of funds for investors to choose from.
But with so much choice, it can be hard to decide which ones to buy. To help readers narrow things down, I have picked out two ETFs which I think are among the best on offer today.
They are as follows:
BetaShares Asia Technology Tigers ETF (ASX: ASIA)
I think the BetaShares Asia Technology Tigers ETF would be a great option for investors. This ETF tracks the performance of the 50 largest technology and ecommerce companies that have their main area of business in Asia, excluding Japan. This includes giants such as Alibaba, Samsung, and Tencent Holdings. As these and the other companies in the ETF are among the fastest growing in the region and revolutionising the lives of billions of people, I believe it could provide strong returns over the 2020s.
iShares Global Healthcare ETF (ASX: IXJ)
Another ETF to consider buying is the iShares Global Healthcare ETF. This exchange traded fund gives investors access to many of the biggest and brightest healthcare companies in the world. This includes CSL Ltd (ASX: CSL), Johnson & Johnson, Novartis, and Ramsay Health Care Limited (ASX: RHC). Due to the positive outlook for the healthcare sector over the next couple of decades due to ageing populations and increased chronic disease, I believe it could provide strong returns for investors.